Navigation Links
PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
Date:3/11/2013

is certain amounts based on net sales of Lucentis, made by Novartis, during calendar year 2011 and beyond. The amount paid is less than we receive in royalties on such sales.

Reported worldwide sales for Avastin sales increased 10 percent in the fourth quarter of 2012 when compared to the same period in 2011.  Ex-U.S. manufactured and sold Avastin sales represented 50 percent of total Avastin sales in the fourth quarter of 2012 as compared with 27 percent in the fourth quarter of 2011.

Reported worldwide sales for Herceptin increased 11 percent in the fourth quarter of 2012 when compared to the same period in 2011. Ex-U.S. manufactured and sold Herceptin sales represented 41 percent of total Herceptin sales in the fourth quarter of 2012 as compared with 35 percent in the fourth quarter of 2011.

Reported worldwide sales for Lucentis increased 12 percent in the fourth quarter of 2012 when compared to the same period in 2011. All sales of Lucentis were from inventory produced in the United States.

Reported worldwide sales for Tysabri increased 16 percent for the fourth quarter of 2012 compared to the same period in 2011. Tysabri royalties are determined at a flat rate as a percentage of sales regardless of location of manufacture or sale.

The sales information presented above is based on information provided by PDL's licensees in their quarterly reports to the Company as well as from public disclosures made by PDL's licensees.

About PDL BioPharma
PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new income generating assets and maximizing value for its shareholders. For more information, please visit www.pdl.com.

NOTE: PDL BioPharma and the PDL BioP
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. PDL BioPharma to Hold Annual Meeting of Stockholders on May 21, 2013
2. Todays Research on PDL BioPharma, Dendreon, Medivation, ACADIA Pharma, and Cell Therapeutics
3. PDL BioPharma Announces Fourth Quarter and Full Year 2012 Financial Results
4. BiOptix to highlight new carbonic anhydrase data at IBCs Biopharmaceutical Development & Production Week
5. Array BioPharma To Present At The Cowen Annual Health Care Conference
6. Keryx Biopharmaceuticals to Present at the Citigroup 2013 Global Healthcare Conference
7. Promise and Problems Signal Mixed Year Ahead for Biopharmaceutical Industry, Says Pharmaceutical Executive Magazine
8. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
9. Array BioPharma To Present At The Leerink Swann Global Healthcare Conference
10. Matinas BioPharma to Present at the NYC Medical Technology Forum on February 5, 2013
11. Keryx Biopharmaceuticals Announces Pricing of Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Mass. , May 21, 2013 /PRNewswire/ ... research and advisory firms for pharmaceutical and ... an emerging agent on key efficacy endpoints, ... progression, has the most influence over surveyed ... advanced/metastatic hormone-receptor (HR-) positive, HER2-negative breast cancer. ...
(Date:5/21/2013)... , May 21, 2013 iHealth ... manufacture of wireless personal healthcare products and a ... reach, announcing the release of two new fitness ... pressure monitors and scales: the Wireless Pulse Oximeter ... (Photo: http://photos.prnewswire.com/prnh/20130521/SF17618 ) iHealth ...
(Date:5/21/2013)... Md. , May 21, 2013 ... disposable drug-free consumer electronic devices, announced that CEO, ... presenting today to the FDA,s Medical Advisory Committee, ... the company,s products for over the counter sales. ... FDA developed its medical device classification schema," Whelan ...
Breaking Medicine Technology:Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2iHealth Lab adds new products and partners to mobile personal healthcare offering 2iHealth Lab adds new products and partners to mobile personal healthcare offering 3BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3
... Calif. and FORT WASHINGTON, Pa., Oct. 19, 2011 ... and fitness measurement utilizing biometric testing devices and ... in consumer focused, health engagement digital messaging, today ... solutions in the retail and non-retail markets. ...
... ATLANTA, Oct. 19, 2011 VaxyGen ... of an exclusive license and collaboration agreement with ... VaxyGen the exclusive license to a novel patent ... biopharmaceutical and vaccine products. In addition, VaxyGen and ...
Cached Medicine Technology:ADFLOW Health Networks and Stayhealthy Form Strategic Partnership to Deploy the Most Comprehensive Biometric Screening and Consumer Health Engagement Platform in U.S. 2ADFLOW Health Networks and Stayhealthy Form Strategic Partnership to Deploy the Most Comprehensive Biometric Screening and Consumer Health Engagement Platform in U.S. 3ADFLOW Health Networks and Stayhealthy Form Strategic Partnership to Deploy the Most Comprehensive Biometric Screening and Consumer Health Engagement Platform in U.S. 4VaxyGen Manufacturing Services LLC Announces Exclusive License and Collaborative Agreement with Georgia State University Research Foundation to Commercialize Novel Biological Process Development Patent, Expertise & Know-How 2VaxyGen Manufacturing Services LLC Announces Exclusive License and Collaborative Agreement with Georgia State University Research Foundation to Commercialize Novel Biological Process Development Patent, Expertise & Know-How 3
(Date:5/21/2013)... New York, New York (PRWEB) May 21, 2013 ... protecting the rights of victims injured by defective medical devices, ... attorney in the case of the Estate of Fred E. ... Kitsap County (Port Orchard). A May 21, 2013, Bloomberg ... Intuitive Surgical had acted like a “car dealership” in how ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Mecklenburg EMS ... will hold a free Community Wellness Fair to educate ... The fair will be held on Wednesday, May 22, 2013 ... City YMCA (8100 Old Mallard Creek Road, Charlotte, NC ... Heart Association and the Mecklenburg County Department of ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Arizona ... inventors who want to develop their ideas into ... program. , The university is recruiting participants ... new “formation space” that provides early-stage entrepreneurs with ... AREA48 is open to anyone, ASU is particularly ...
(Date:5/21/2013)... Diversity Focus, a non-profit organization striving to improve the ... Creative Corridor region, is releasing results for its 2013 ... Thursday, May 23rd at 10:30 a.m. The survey ... , The survey is a critical component to the ... nurture and retain people of diverse backgrounds, cultures and ...
(Date:5/21/2013)... the roles two proteins, thrombospondin-1 and prosaposin, play ... has identified a five-amino acid fragment of prosaposin ... of prostate, breast and lung cancer. The findings ... metastasis in a variety of cancers. , ... at Boston Children,s Hospital, Vivek Mittal, PhD, at ...
Breaking Medicine News(10 mins):Health News:Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership 2Health News:Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership 3Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 3Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 4Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2Health News:Changing cancer's environment to halt its spread 2Health News:Changing cancer's environment to halt its spread 3
... impotence study uses soft words about hard seats suggesting ... needed to determine the cause, " says patent-granted author ... conclude motorcycle seats as causation for impotence.""Bicycling or hard ... on the groin rather than modern day cruising seats. ...
... bone cement and a well known antibiotic, may effectively ... fractures, according to a study published online today in ... search for solutions is underway as 20,000 additional American ... the infection studied may set the stage for more ...
... The Risk Management and Patient,Safety Institute ... management,practices and patient safety programs for health ... license partnership with Salus Global,Corporation to market ... to U.S. hospitals and health care systems. ...
... AvMed Health Plans, one of Florida,s,leading ... health plan,options to residents of Miami-Dade and ... The competitively-priced plans-being offered collectively through AvMed,Individual ... plans also are available for 2-year-olds to ...
... Blood & Tissue Center to Implement 3 Integrated ... Inc. ("Global Med" or the "Company") (OTC Bulletin ... company, today announced that its Wyndgate Technologies(R) division ... Doc(TM) integrated donor management systems to South Texas ...
... MedPro Imaging, a premier provider,of economical ultrasound solutions, ... ending 2008 compared to 2007. A number of multiple,system ... by St. Anthony Hospital, a leading Healthcare provider in ... "The wide variety of choices available through ...
Cached Medicine News:Health News:Motorcycle Seats NOT The Cause of Impotence or Erectile Dysfunction for Bikers 2Health News:New twist on old medical technology may prevent amputations 2Health News:New twist on old medical technology may prevent amputations 3Health News:New twist on old medical technology may prevent amputations 4Health News:The Risk Management and Patient Safety Institute Announces Exclusive Partnership with Salus Global Corporation to Launch MORE(OB) to U.S. Market 2Health News:The Risk Management and Patient Safety Institute Announces Exclusive Partnership with Salus Global Corporation to Launch MORE(OB) to U.S. Market 3Health News:The Risk Management and Patient Safety Institute Announces Exclusive Partnership with Salus Global Corporation to Launch MORE(OB) to U.S. Market 4Health News:AvMed Health Plans Launches New Individual Health Plan Options in South Florida 2Health News:Global Med Technologies(R) Licenses Multi-System Solution to One of Top Ten U.S. Donor Centers 2Health News:Global Med Technologies(R) Licenses Multi-System Solution to One of Top Ten U.S. Donor Centers 3Health News:Global Med Technologies(R) Licenses Multi-System Solution to One of Top Ten U.S. Donor Centers 4Health News:MedPro Reports 127 Percent Revenue Growth in 2008 2
... Mumps IgM Enzyme-Linked Immunosorbent Assay ... qualitative detection of IgM antibody ... for the determination of immunological ... this kit have not been ...
The DSL 05-10-MUM Mumps IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Mumps virus in human serum. This assay is intended for in...
... announced the launch of the Chilli ... bi-directional cooled-tip catheter available in the United ... physicians the benefits of cooled ablation technology ... Boston Scientific Blazer(R) catheter platform. ,Cooled cardiac ...
... wire crosses the lesion first, independent of ... actions, including filter placement and retrieval, balloon ... the wire., ,Emboshield is designed to capture ... carotid stenting procedure, and it is the ...
Medicine Products: